Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
India
/
Pharmaceuticals & Biotech
/
NATCO Pharma
NATCOPHARM
NATCO Pharma
NATCO Pharma's Future Looks Bright as Profit Margins Surge by 42.56%
SN
SNKRRMGM
Invested
Community Contributor
Published
09 Aug 25
Updated
09 Aug 25
1
Set Fair Value
0
votes
Share
SNKRRMGM
's Fair Value
₹1,236.00
29.3% undervalued
intrinsic discount
09 Aug
₹874.45
Loading
1Y
-40.0%
7D
-2.8%
Author's Valuation
₹1.2k
29.3% undervalued
intrinsic discount
SNKRRMGM's Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
SNKRRMGM
's
Fair Value
₹1.2k
29.3% undervalued
intrinsic discount
Future estimation in
5 Years
time period
Past
Future
0
110b
2014
2017
2020
2023
2025
2026
2029
2030
Revenue ₹109.8b
Earnings ₹46.7b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
-16.23%
Pharma revenue growth rate
0.58%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
12.73%
Calculation
₹46.72b
Earnings '30
x
8.62x
PE Ratio '30
=
₹402.91b
Market Cap '30
₹402.91b
Market Cap '30
/
179.08m
No. shares '30
=
₹2.25k
Share Price '30
₹2.25k
Share Price '30
Discounted to 2025 @ 12.73% p.a.
=
₹1.24k
Fair Value '25
